STOCK TITAN

BIO-key International, Inc. - BKYI STOCK NEWS

Welcome to our dedicated page for BIO-key International news (Ticker: BKYI), a resource for investors and traders seeking the latest updates and insights on BIO-key International stock.

BIO-key International, Inc. (OTCQB: BKYI) is a leading provider of biometric software and hardware authentication solutions for enterprises and consumers alike. Established in 1993, BIO-key has become a trusted name, servicing diverse sectors including Fortune 500 companies, government agencies, healthcare organizations, call centers, schools, retailers, and OEM partners.

BIO-key's product portfolio includes advanced fingerprint biometric identification and identity verification technologies, with popular offerings such as SideSwipe, SidePass, EcoID, and WEB-key. The company's innovative solutions ensure secure and seamless access management, making them a preferred choice for high-security requirements.

In 2016, BIO-key introduced a series of compact fingerprint readers designed for compatibility with Windows Hello. These readers are not only affordable but also easy to install and use, available through major retailers like Amazon, Microsoft, and Dell.com. The company further expanded its consumer reach by launching a series of biometric padlocks at the Consumer Electronics Show in 2017. Their product, TouchLock, received significant acclaim, being featured on over 30 morning television shows.

BIO-key continues to innovate with its 'Biometric of Things' (BoT) initiative, aiming to create a range of biometrically enabled, consumer-friendly products. The company’s focus on the power of a touch drives their mission to enhance security and user experience across various applications.

Financially, BIO-key generates revenue through services, license fees, and other streams. The company remains committed to partnerships and collaborations that expand their market presence and technological capabilities.

One notable partnership is with Humanity International Investments, under the chairmanship of His Highness, Sheikh Marwan bin Mohamed bin Rashid Al Maktoum. This strategic collaboration has led to the launch of the Humanity Protocol, a blockchain-based economic empowerment initiative. The project leverages BIO-key’s biometric palm scan technology to authenticate identities, enabling individuals, particularly in Africa, to claim their digital footprint through Non-Fungible Tokens (NFTs). With over 15,000 palm scans and plans to verify more users, the initiative marks a significant step forward in integrating biometric technology with blockchain for identity verification.

Overall, BIO-key International, Inc. is at the forefront of revolutionizing digital identity and access management, ensuring secure, user-friendly authentication solutions for millions worldwide.

Rhea-AI Summary
BIO-key International, Inc. (BKYI) announced a collaboration with Haver & Boecker to implement Multifactor Authentication (MFA) and Single Sign-On (SSO) technology for its digital platforms. This strategic initiative aims to enhance efficiency and user experience for the company's employees, reflecting a commitment to adopting innovative technologies. The modernization will allow access to multiple applications and services, eliminating the complexity of managing numerous passwords. The collaboration with P&W Network demonstrates a forward-thinking approach to digital transformation, emphasizing security and efficiency.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.14%
Tags
none
-
Rhea-AI Summary
BIO-key International, Inc. (NASDAQ: BKYI) will present at DealFlow Event’s Microcap Conference, highlighting a 39% revenue growth to $8.6M in the 12 months ended Sept 30, 2023. The company reported reduced losses and a market cap of approximately $4M based on Friday’s closing price of $2.03. CEO Mike DePasquale will present on January 31st at 10:50am ET, and the conference will feature insights into trading strategies, regulations, and risk assessment.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.91%
Tags
none
-
Rhea-AI Summary
BIO-key International, an innovative provider of passwordless, phoneless, and token-less Identity and Access Management (IAM) Multifactor Authentication (MFA) solutions, announced that Fargo, North Dakota and Junction City, Kansas have selected BIO-key PortalGuard and its phoneless and tokenless Identity Bound Biometric (IBB) authentication options to add phish-resistance, enhance information security, and streamline workflows. The adoption of BIO-key’s biometric authentication solutions reflects a shift towards a more efficient, cost-effective, and user-friendly approach to securely authenticating to municipal digital services. The company's NIST- and independent lab-tested biometric security technology measures and compares unique biometric characteristics of users to verify and authenticate them, eliminating the need to carry phones or per-user tokens in order to access systems and get things done. Implementing biometric authentication in Fargo and Junction City ensures a more robust and reliable defense against unauthorized access to the cities’ systems. Customers save money by choosing BIO-key PortalGuard’s biometric factors, leading to decreased reliance on costly physical identification factors such as hardware tokens, access cards, or users’ phones.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8%
Tags
none
Rhea-AI Summary
BIO-key International, an innovative provider of workforce and customer Identity and Access Management solutions, announced that its Access Management platform, PortalGuard® IDaaS, won a 2024 BIG Innovation Award in the Software category. The company's unique Identity Bound Biometrics (IBB) capabilities differentiate it in the authentication market, offering secure and privacy-law-compliant biometric authentication factors that allow every user to be their own credential. With a focus on phish-resistant MFA and passwordless authentication, BIO-key's award-winning unified IAM platform, PortalGuard® IDaaS, along with IBB, provides flexible options for authentication, including biometric-secured tokenless, phoneless options for everyday sign-in and self-service account recovery.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.74%
Tags
none
-
Rhea-AI Summary
BIO-key International, Inc. (BKYI) partners with IT2Trust to enhance digital security infrastructure for the Ministry of Foreign Affairs of Denmark, deploying a state-of-the-art Virtual Private Network secured by BIO-key Europe’s AuthControl Sentry authentication solution.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.64%
Tags
none
-
Rhea-AI Summary
BIO-key International, Inc. (NASDAQ: BKYI) announced the implementation of a Virtual Private Network (VPN) secured by BIO-key Swivel Secure authentication technology AuthControl Sentry for the Judiciary Police of Portugal, in collaboration with Securnet. The deployment significantly enhances operational security and efficiency for the Judiciary Police, supporting their fight against organized crime, terrorism, drug trafficking, corruption, and financial crimes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.33%
Tags
none
Rhea-AI Summary
BIO-key International, Inc. (NASDAQ: BKYI) announced a strategic collaboration with Carrefour, a leading global retailer, to integrate BIO-key’s AuthControl Sentry® cloud solution in Spain in collaboration with Evolutio. The solution will safeguard the authentication process for Carrefour’s 6,500 Spanish employees, reinforcing the company’s commitment to operational excellence and data security.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.91%
Tags
partnership
-
News
Rhea-AI Summary
BIO-key International, Inc. (NASDAQ: BKYI) announced the full repayment of its $2.2M senior secured note, eliminating all long-term debt, and completing a $550,000 private placement of units at a premium to market. The company's CEO, Michael DePasquale, highlighted the efforts to strengthen the company's financial position, including the completion of $4.3M in equity funding over the past two months.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.17%
Tags
none
-
Rhea-AI Summary
BIO-key International, Inc. (Nasdaq: BKYI) has approved a 1-for-18 reverse stock split to regain compliance with the minimum bid price requirement. The company had approximately 16.9 million shares of common stock issued and outstanding as of December 19, 2023, and will have approximately 941,000 shares after the reverse split. CEO Michael DePasquale stated that the decision was intended to position their common stock for ongoing minimum bid price compliance as they execute on their growth and profitability goals in 2024 and beyond.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.88%
Tags
none
Rhea-AI Summary
BIO-key International, Inc. (NASDAQ: BKYI) announced that Genesis HealthCare System, the largest healthcare provider in its six-county region of Ohio, will add BIO-key’s PortalGuard IAM platform to support its existing BIO-key biometric authentication investment as it migrates to Epic Systems’ Hyperdrive end-user application interface. This move allows Genesis HealthCare to continue enjoying the security and streamlined biometric authentication user experience that BIO-key provides without re-enrolling employees or adopting more cumbersome and expensive multi-factor authentication solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.33%
Tags
none

FAQ

What is the current stock price of BIO-key International (BKYI)?

The current stock price of BIO-key International (BKYI) is $0.9515 as of December 23, 2024.

What is the market cap of BIO-key International (BKYI)?

The market cap of BIO-key International (BKYI) is approximately 3.5M.

What does BIO-key International, Inc. do?

BIO-key is a provider of biometric software and hardware authentication solutions for enterprises and consumers, offering products like fingerprint readers and identity verification technologies.

When was BIO-key International, Inc. established?

BIO-key was established in 1993.

Who are BIO-key's customers?

BIO-key's customers include Fortune 500 companies, government agencies, healthcare organizations, call centers, schools, retailers, and OEM partners.

What are some popular products offered by BIO-key?

Some popular products include SideSwipe, SidePass, EcoID, WEB-key, and biometric padlocks like TouchLock.

What is the 'Biometric of Things' (BoT) initiative?

The BoT initiative aims to create biometrically enabled, consumer-friendly products that enhance security and user experience.

How does BIO-key generate revenue?

BIO-key generates revenue through services, license fees, and other streams.

What is the Humanity Protocol?

The Humanity Protocol is a blockchain-based economic empowerment initiative that uses BIO-key's biometric palm scan technology for identity verification, allowing individuals to claim their digital footprint through NFTs.

Who are BIO-key’s strategic partners?

One notable strategic partner is Humanity International Investments, led by His Highness, Sheikh Marwan bin Mohamed bin Rashid Al Maktoum.

Where can BIO-key products be purchased?

BIO-key products can be purchased through major retailers like Amazon, Microsoft, and Dell.com.

What type of biometric technology does BIO-key specialize in?

BIO-key specializes in fingerprint biometric technology for identification and identity verification.

BIO-key International, Inc.

Nasdaq:BKYI

BKYI Rankings

BKYI Stock Data

3.50M
2.93M
5.58%
9.26%
27.83%
Security & Protection Services
Services-prepackaged Software
Link
United States of America
HOLMDEL